Blue Sparrow’s CG Oncology CGON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$9.8M Buy
+137,900
New +$10.1M 0.12% 113

Other funds holding CGON

Blue Sparrow's CGON Position: Q3 2026 in Review

Blue Sparrow opened a new position in CG Oncology (CGON) in Q3 2026: 137,900 shares worth $9.8M. The stake represents 0.12% of the portfolio and ranks #113 among its holdings.

230 funds tracked by Wall St. Rank hold CGON as of Q3 2026.

  • Blue Sparrow held 137,900 shares of CG Oncology worth $9.8M as of Q3 2026.
  • CG Oncology was a new Blue Sparrow position in Q3 2026.
  • CG Oncology made up 0.12% of Blue Sparrow's portfolio in Q3 2026, its #113 holding.
  • 230 funds tracked by Wall St. Rank held CG Oncology as of Q3 2026.

Based on Blue Sparrow's 13F filing for Q3 2026, filed 16 Nov 2026.